<p><strong>NEW DELHI:</strong> For $139.4 million, Jubilant Pharma, a division of Jubilant Pharmova, will sell its whole 25.8% ownership in Sofie Biosciences, a US company. According to a statement from the firm, Singapore-based Jubilant Pharma contributed $25 million to Sofie in November 2020.</p>
<p><img decoding=”async” class=”alignnone wp-image-382453″ src=”https://www.theindiaprint.com/wp-content/uploads/2024/01/theindiaprint.com-jubilant-co-is-set-to-sell-a-139-million-interest-in-a-us-corporation-107274025-1.png” alt=”theindiaprint.com jubilant co is set to sell a 139 million interest in a us corporation 107274025 1″ width=”1017″ height=”572″ title=”Jubilant Co. is set to sell a $139 million interest in a US corporation 15″ srcset=”https://www.theindiaprint.com/wp-content/uploads/2024/01/theindiaprint.com-jubilant-co-is-set-to-sell-a-139-million-interest-in-a-us-corporation-107274025-1.png 400w, https://www.theindiaprint.com/wp-content/uploads/2024/01/theindiaprint.com-jubilant-co-is-set-to-sell-a-139-million-interest-in-a-us-corporation-107274025-1-390×220.png 390w, https://www.theindiaprint.com/wp-content/uploads/2024/01/theindiaprint.com-jubilant-co-is-set-to-sell-a-139-million-interest-in-a-us-corporation-107274025-1-150×84.png 150w” sizes=”(max-width: 1017px) 100vw, 1017px” /></p>
<p>Sofie is a company that develops and provides molecular medicines and diagnostics (theranostics). It possesses an advanced contract manufacturing services network, a radiopharmaceutical production and distribution network, and valuable therapeutic intellectual property.<br />
It and several private equity groups have recently finalized their merger deal.</p>
